Skip to main content
logo
Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.700
+0.050 (1.37%)
At close: May 18, 2026, 4:00 PM EDT
3.790
+0.090 (2.43%)
Pre-market: May 19, 2026, 6:20 AM EDT

Niagen Bioscience Market Cap

Niagen Bioscience has a market cap or net worth of $295.3 million as of May 19, 2026. Its market cap has decreased by -52.52% in one year.

Market Cap
295.30M
Enterprise Value
231.48M
1-Year Change
-52.52%
Ranking
#3568
Category
Micro-Cap
Stock Price
$3.70

Market Cap Chart

Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $295.30M, a decrease of -67.54%. That is a compound annual growth rate of -6.09%.

History

DateMarket Cap% Change
May 18, 2026294.70M-41.94%
Dec 31, 2025507.60M25.27%
Dec 31, 2024405.20M277.28%
Dec 29, 2023107.40M-14.15%
Dec 30, 2022125.10M-51.02%
Dec 31, 2021255.40M-13.89%
Dec 31, 2020296.60M15.50%
Dec 31, 2019256.80M35.87%
Dec 31, 2018189.00M-33.29%
Dec 29, 2017283.30M125.74%
Dec 30, 2016125.50M-5.71%
Dec 31, 2015133.10M41.45%
Dec 31, 201494.10M-40.97%
Dec 31, 2013159.40M224.64%
Dec 31, 201249.10M19.76%
Dec 30, 201141.00M-49.88%
Dec 31, 201081.80M544.09%
Dec 31, 200912.70M-95.35%
Dec 31, 2008272.90M-70.00%
Jun 25, 2008909.70M-
View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Palisade Bio306.39M
Cellectis302.34M
REGENXBIO295.71M
Armata Pharmaceuticals295.40M
Inhibikase Therapeutics294.83M
Eledon Pharmaceuticals293.75M
Nuvectis Pharma292.84M
NervGen Pharma288.52M
Market Cap Rankings